Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04141111Not ApplicableCompleted

Retrospective and Prospective Study on Professional Continuous Glucose Monitoring in Insulin-treated Type 2 Diabetes

Role: lead

NCT02845791Not ApplicableCompleted

PRE-STARt Intervention - Trial of an Interactive Family Based Lifestyle Programme

Role: collaborator

NCT02545140Completed

Prevention Strategies for Adolescents at Risk of Diabetes

Role: collaborator

NCT03678896Not ApplicableCompleted

Creative Writing for Type 2 Diabetes Management

Role: lead

All 4 trials loaded